BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lo SS, Moffatt-bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011;8:405-16. [DOI: 10.1038/nrclinonc.2011.75] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Yeung R, Hamm J, Liu M, Schellenberg D. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases. Radiat Oncol 2017;12:105. [PMID: 28637480 DOI: 10.1186/s13014-017-0820-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
2 Ai D, Chen Y, Liu Q, Deng J, Zhao K. The effect of tumor locations of esophageal cancer on the metastasis to liver or lung. J Thorac Dis 2019;11:4205-10. [PMID: 31737304 DOI: 10.21037/jtd.2019.09.67] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro. Anticancer Res. 2012;32:2249-2256. [PMID: 22641659 DOI: 10.1016/j.semcancer.2012.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 AlSendi M, O'Reilly D, Zeidan YH, Kelly CM. Oligometastatic breast cancer: Are we there yet? Int J Cancer 2021;149:1520-8. [PMID: 34013530 DOI: 10.1002/ijc.33693] [Reference Citation Analysis]
5 Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012;9:193-9. [PMID: 22408567 DOI: 10.7150/ijms.3635] [Cited by in Crossref: 695] [Cited by in F6Publishing: 569] [Article Influence: 69.5] [Reference Citation Analysis]
6 Furman MJ, Whalen GF, Shah SA, Kadish SP. Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer. Pract Radiat Oncol 2013;3:40-4. [PMID: 24674262 DOI: 10.1016/j.prro.2012.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
7 Neerincx M, Poel D, Sie DLS, van Grieken NCT, Shankaraiah RC, van der Wolf-de Lijster FSW, van Waesberghe JTM, Burggraaf JD, Eijk PP, Verhoef C, Ylstra B, Meijer GA, van de Wiel MA, Buffart TE, Verheul HMW. Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer. PLoS One 2018;13:e0201809. [PMID: 30075027 DOI: 10.1371/journal.pone.0201809] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
8 Zhao Y, Li J, Li D, Wang Z, Zhao J, Wu X, Sun Q, Lin PP, Plum P, Damanakis A, Gebauer F, Zhou M, Zhang Z, Schlösser H, Jauch KW, Nelson PJ, Bruns CJ. Tumour biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.Semin Cancer Biol. 2020;60:334-343. [PMID: 31445220 DOI: 10.1016/j.semcancer.2019.08.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fernando W, Rupasinghe HPV, Hoskin DW. Dietary phytochemicals with anti-oxidant and pro-oxidant activities: A double-edged sword in relation to adjuvant chemotherapy and radiotherapy? Cancer Lett 2019;452:168-77. [PMID: 30910593 DOI: 10.1016/j.canlet.2019.03.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
10 Zeng F, Lu T, Xie F, Chen L, Zhang L, Su Y, Yu Z, Xiao Y, Ao F, Li G, Chen Z, Gong X, Li J. Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study. Transl Oncol 2021;14:101187. [PMID: 34365221 DOI: 10.1016/j.tranon.2021.101187] [Reference Citation Analysis]
11 Hoffe S, Balducci L. Cancer and Age: General Considerations. Clinics in Geriatric Medicine 2012;28:1-18. [DOI: 10.1016/j.cger.2011.09.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
12 O'Sullivan S, Cagney DN. The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective. Ir J Med Sci 2018;187:887-94. [PMID: 29423821 DOI: 10.1007/s11845-018-1755-8] [Reference Citation Analysis]
13 Onishi H, Ozaki M, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Oguri M, Watanabe I, Onohara K, Watanabe M, Sano N, Araki T. Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature. Pulm Med 2012;2012:713073. [PMID: 23150822 DOI: 10.1155/2012/713073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chua ML, Tan SH, Kusumawidjaja G, Shwe MT, Cheah SL, Fong KW, Soong YL, Wee JT, Tan TW. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials. Eur J Cancer 2016;67:119-29. [PMID: 27640138 DOI: 10.1016/j.ejca.2016.08.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
15 Quirk MT, Pomykala KL, Suh RD. Current readings: Percutaneous ablation for pulmonary metastatic disease. Semin Thorac Cardiovasc Surg 2014;26:239-48. [PMID: 25527018 DOI: 10.1053/j.semtcvs.2014.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
16 Beckham TH, Yang TJ, Gomez D, Tsai CJ. Metastasis-directed therapy for oligometastasis and beyond. Br J Cancer 2021;124:136-41. [PMID: 33204024 DOI: 10.1038/s41416-020-01128-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bourgier C, Azria D, Fenoglietto P, Riou O, Almaghrabi MY, Supiot S, Mornex F, Giraud P. [Stereotactic body radiation therapy and oligometastases]. Cancer Radiother 2014;18:337-41. [PMID: 24792996 DOI: 10.1016/j.canrad.2014.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
18 Lee YH, Kang KM, Choi HS, Ha IB, Jeong H, Song JH, Jang IS, Kim SH, Lee JW, Rhee DY, Jeong BK. Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases. Thorac Cancer 2018;9:1671-9. [PMID: 30298701 DOI: 10.1111/1759-7714.12880] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
19 Sauter M, Vavricka SR, Keilholz G, Heinrich H, Winder T, Kranzbühler H, Lombriser N, Misselwitz B. Surveillance of anal carcinoma after radiochemotherapy: A retrospective analysis of 80 patients. Strahlenther Onkol 2017;193:639-47. [DOI: 10.1007/s00066-017-1159-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Li J, Xie Q, Wang W, Hua Y, Cheng Y, Li L, Zhu X. CT-guided implantation of 125I seeds (permanent brachytherapy) for metastatic tumors of the hepatic portal system: Effectiveness and safety in 13 patients. Brachytherapy 2016;15:224-30. [DOI: 10.1016/j.brachy.2015.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Wujanto C, Vellayappan B, Siva S, Louie AV, Guckenberger M, Slotman BJ, Onishi H, Nagata Y, Liu M, Lo SS. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer. Front Oncol 2019;9:1219. [PMID: 31799188 DOI: 10.3389/fonc.2019.01219] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
22 Rashdan S, Iyengar P, Minna JD, Gerber DE. Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer. Transl Lung Cancer Res 2021;10:3351-68. [PMID: 34430372 DOI: 10.21037/tlcr-21-448] [Reference Citation Analysis]
23 Colloca G, Tagliaferri L, Capua BD, Gambacorta MA, Lanzotti V, Bellieni A, Monfardini S, Balducci L, Bernabei R, Cho WC, Valentini V. Management of The Elderly Cancer Patients Complexity: The Radiation Oncology Potential. Aging Dis 2020;11:649-57. [PMID: 32489709 DOI: 10.14336/AD.2019.0616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Wang GZ, He XH, Wang Y, Xu LC, Huang HZ, Wang YH, Shen Z, Qu XD, Ding XY, Yang JJ, Li WT. Clinical practice guideline for image-guided multimode tumour ablation therapy in hepatic malignant tumours. Curr Oncol 2019;26:e658-64. [PMID: 31708659 DOI: 10.3747/co.26.5423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Le QT, Shirato H, Giaccia AJ, Koong AC. Emerging Treatment Paradigms in Radiation Oncology. Clin Cancer Res 2015;21:3393-401. [PMID: 25991820 DOI: 10.1158/1078-0432.CCR-14-1191] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
26 Yamamoto T, Jingu K, Shirata Y, Koto M, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Abe K, Kadoya N, Ishikawa Y, Kozumi M, Takahashi N, Takeda K, Takai Y. Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors. BMC Cancer 2014;14:464. [PMID: 24957478 DOI: 10.1186/1471-2407-14-464] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
27 Ning MS, Deegan BJ, Ho JC, Chapman BV, Bishop AJ, Allen PK, Tannir NM, Amini B, Briere TM, Wang XA, Tatsui CE, Rhines LD, Brown PD, Li J, Ghia AJ. Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. Radiotherapy and Oncology 2019;138:80-5. [DOI: 10.1016/j.radonc.2019.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Li J, Zhang L, Xu W, Wang T, Zhou L, Xie Q, Wang W, Hua Y. Computed tomography-guided implantation of 125I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results. J Contemp Brachytherapy 2017;9:132-8. [PMID: 28533801 DOI: 10.5114/jcb.2017.67023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
29 Yang LY, Chang RM, Lau WY, Ou DP, Wu W, Zeng ZJ. Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes. Surgery. 2014;156:1177-1187. [PMID: 25444316 DOI: 10.1016/j.surg.2014.05.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
30 Deschamps F, Farouil G, Ternes N, Gaudin A, Hakime A, Tselikas L, Teriitehau C, Baudin E, Auperin A, de Baere T. Thermal ablation techniques: a curative treatment of bone metastases in selected patients? Eur Radiol 2014;24:1971-80. [DOI: 10.1007/s00330-014-3202-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 9.1] [Reference Citation Analysis]
31 Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol 2017;18:e653-706. [PMID: 29208398 DOI: 10.1016/S1470-2045(17)30698-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 16.6] [Reference Citation Analysis]
32 Lyu J, Li T, Wang Q, Li F, Diao P, Liu L, Li C, Lang J. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study. Radiat Oncol 2018;13:233. [PMID: 30477531 DOI: 10.1186/s13014-018-1183-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Lukovic J, Rodrigues G. Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer. Cureus 2015;7:e365. [PMID: 26623220 DOI: 10.7759/cureus.365] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Kelly P, Ma Z, Baidas S, Moroose R, Shah N, Dagan R, Mamounas E, Rineer J. Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy. Int J Breast Cancer 2017;2017:1367159. [PMID: 29147583 DOI: 10.1155/2017/1367159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
35 Duru Birgi S, Akgun Z, Hurmuz P, Akyurek S, Kaytan Saglam E, Yilmaz MT, Bakirarar B, Cengiz M. Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non-small Cell Lung Cancer Patients: Turkish Society for Radiation Oncology Group Study (TROD 10-003). Am J Clin Oncol 2022;45:40-7. [PMID: 34857699 DOI: 10.1097/COC.0000000000000881] [Reference Citation Analysis]
36 Loi M, Magallon-baro A, Papalazarou C, Milder M, Nuyttens J. Robotic stereotactic treatment for malignant metastasis of solid tumour in the pancreas: A multiple case report and review of literature. Cancer/Radiothérapie 2017;21:784-7. [DOI: 10.1016/j.canrad.2017.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
37 Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S; SIOG Radiotherapy Task Force. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. Ann Oncol 2014;25:2134-46. [PMID: 24625455 DOI: 10.1093/annonc/mdu104] [Cited by in Crossref: 65] [Cited by in F6Publishing: 35] [Article Influence: 8.1] [Reference Citation Analysis]
38 Franco P, De Bari B, Ciammella P, Fiorentino A, Chiesa S, Amelio D, Pinzi V, Bonomo P, Vagge S, Fiore M, Comito T, Cecconi A, Mortellaro G, Bruni A, Trovo' M, Filippi AR, Greto D, Alongi F. The Role of Stereotactic Ablative Radiotherapy in Oncological and Non-Oncological Clinical Settings: Highlights from the 7 th Meeting of AIRO – Young Members Working Group (AIRO Giovani). Tumori Journal 2018;100:e214-29. [DOI: 10.1177/1778.19280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
39 Kim C, Hoang CD, Kesarwala AH, Schrump DS, Guha U, Rajan A. Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. J Thorac Oncol 2017;12:179-93. [PMID: 27780780 DOI: 10.1016/j.jtho.2016.10.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
40 Dawson LA. Overview: Where does radiation therapy fit in the spectrum of liver cancer local-regional therapies? Semin Radiat Oncol. 2011;21:241-246. [PMID: 21939852 DOI: 10.1016/j.semradonc.2011.05.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
41 Chang HJ, Ko HL, Lee CY, Wu RH, Yeh YW, Jiang JS, Kao SJ, Chi KH. Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy. Radiat Oncol 2012;7:222. [PMID: 23268786 DOI: 10.1186/1748-717X-7-222] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
42 Hasegawa T, Kuroda H, Sakakura N, Sato Y, Chatani S, Murata S, Yamaura H, Nakada T, Oya Y, Inaba Y. Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation. Thorac Cancer 2021;12:2085-92. [PMID: 34106518 DOI: 10.1111/1759-7714.14041] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Lock MI, Klein J, Chung HT, Herman JM, Kim EY, Small W, Mayr NA, Lo SS. Strategies to tackle the challenges of external beam radiotherapy for liver tumors. World J Hepatol 2017; 9(14): 645-656 [PMID: 28588749 DOI: 10.4254/wjh.v9.i14.645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
44 McPartlin A, Swaminath A, Wang R, Pintilie M, Brierley J, Kim J, Ringash J, Wong R, Dinniwell R, Craig T, Dawson LA. Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases. Int J Radiat Oncol Biol Phys. 2017;99:388-395. [PMID: 28871989 DOI: 10.1016/j.ijrobp.2017.04.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
45 Zhang W, Wang F, Hu C, Zhou Y, Gao H, Hu J. The progress and perspective of nanoparticle-enabled tumor metastasis treatment. Acta Pharm Sin B 2020;10:2037-53. [PMID: 33304778 DOI: 10.1016/j.apsb.2020.07.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
46 He J, Li Y, An J, Hu L, Zhang J. Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis. World J Surg Oncol 2017;15:36. [PMID: 28148271 DOI: 10.1186/s12957-017-1105-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
47 Cerri M, Tinganelli W, Negrini M, Helm A, Scifoni E, Tommasino F, Sioli M, Zoccoli A, Durante M. Hibernation for space travel: Impact on radioprotection. Life Sciences in Space Research 2016;11:1-9. [DOI: 10.1016/j.lssr.2016.09.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
48 Garg AK, Shiu AS, Yang J, Wang XS, Allen P, Brown BW, Grossman P, Frija EK, McAleer MF, Azeem S, Brown PD, Rhines LD, Chang EL. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 2012;118:5069-77. [PMID: 22511344 DOI: 10.1002/cncr.27530] [Cited by in Crossref: 120] [Cited by in F6Publishing: 93] [Article Influence: 12.0] [Reference Citation Analysis]
49 Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. Int J Radiat Oncol Biol Phys. 2012;84:e61-e67. [PMID: 22503522 DOI: 10.1016/j.ijrobp.2012.02.054] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
50 Kendal WS. Oligometastasis as a predictor for occult disease. Math Biosci 2014;251:1-10. [PMID: 24560886 DOI: 10.1016/j.mbs.2014.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
51 Zhang JT, Liu SY, Yan HH, Wu YL, Nie Q, Zhong WZ. Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study. BMC Cancer 2019;19:1051. [PMID: 31694572 DOI: 10.1186/s12885-019-6216-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Smyth LM, Day LR, Woodford K, Rogers PA, Crosbie JC, Senthi S. Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy: A treatment planning study. Physica Medica 2019;60:111-9. [DOI: 10.1016/j.ejmp.2019.03.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
53 Filippi AR, Guerrera F, Badellino S, Ceccarelli M, Castiglione A, Guarneri A, Spadi R, Racca P, Ciccone G, Ricardi U, Ruffini E. Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer. Clin Oncol (R Coll Radiol) 2016;28:505-12. [PMID: 26899780 DOI: 10.1016/j.clon.2016.02.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
54 Lock MI, Hoyer M, Bydder SA, Okunieff P, Hahn CA, Vichare A, Dawson LA. An international survey on liver metastases radiotherapy. Acta Oncol. 2012;51:568-574. [PMID: 22559157 DOI: 10.3109/0284186x.2012.681700] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
55 Lin Q, Zhou N, Zhu X, Lin J, Fang J, Gu F, Sun X, Wang Y. Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis. J Radiat Res 2021:rrab118. [PMID: 34958672 DOI: 10.1093/jrr/rrab118] [Reference Citation Analysis]
56 Li Y, Ou X, Hu C. Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study. J Cancer 2019;10:620-6. [PMID: 30719159 DOI: 10.7150/jca.28554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Pembroke CA, Fortin B, Kopek N. Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression. Radiotherapy and Oncology 2018;127:493-500. [DOI: 10.1016/j.radonc.2018.04.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
58 Ruers TJ, Hagendoorn J. Treatment dilemmas in patients with synchronous colorectal liver metastases. Recent Results Cancer Res 2012;196:37-49. [PMID: 23129365 DOI: 10.1007/978-3-642-31629-6_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
59 Plasencia Martínez JM. Pulmonary radiofrequency ablation (Part 1): current state. Radiologia 2015;57:275-86. [PMID: 25766072 DOI: 10.1016/j.rx.2014.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Li S, Dong D, Geng J, Zhu X, Shi C, Zhang Y, Wang H, Zhou S, Wu H, Cai Y, Li Y, Wang W. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer. Front Oncol 2019;9:1080. [PMID: 31681609 DOI: 10.3389/fonc.2019.01080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
61 Huo D, Zhu J, Chen G, Chen Q, Zhang C, Luo X, Jiang W, Jiang X, Gu Z, Hu Y. Eradication of unresectable liver metastasis through induction of tumour specific energy depletion. Nat Commun 2019;10:3051. [PMID: 31296864 DOI: 10.1038/s41467-019-11082-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
62 Ai D, Zhu H, Ren W, Chen Y, Liu Q, Deng J, Ye J, Fan J, Zhao K. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis. 2017;9:3023-3030. [PMID: 29221275 DOI: 10.21037/jtd.2017.08.72] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
63 Yu J, Li N, Tang Y, Wang X, Tang Y, Wang SL, Song YW, Liu YP, Li YX, Jin J. Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases. J Surg Oncol 2019;119:532-8. [PMID: 30609038 DOI: 10.1002/jso.25361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
64 Kobayashi K, Murakami N, Takahashi K, Inaba K, Hamamoto R, Itami J. Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation. In Vivo 2019;33:1659-65. [DOI: 10.21873/invivo.11652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Wang Y, Du W, Zhang T, Zhu Y, Ni Y, Wang C, Sierra Raya FM, Zou L, Wang L, Liang G. A Self-Evaluating Photothermal Therapeutic Nanoparticle. ACS Nano 2020;14:9585-93. [PMID: 32806081 DOI: 10.1021/acsnano.9b10144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
66 Wu SY, Chen CL, Tseng PC, Chiu CY, Lin YE, Lin CF. Fractionated ionizing radiation facilitates interferon-γ signaling and anticancer activity in lung adenocarcinoma cells. J Cell Physiol 2019. [PMID: 30767202 DOI: 10.1002/jcp.28258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
67 Zhao J, Yorke ED, Li L, Kavanagh BD, Li XA, Das S, Miften M, Rimner A, Campbell J, Xue J, Jackson A, Grimm J, Milano MT, Spring Kong FM. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. Int J Radiat Oncol Biol Phys 2016;95:1357-66. [PMID: 27325482 DOI: 10.1016/j.ijrobp.2016.03.024] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 13.0] [Reference Citation Analysis]
68 Shultz DB, Filippi AR, Thariat J, Mornex F, Loo BW Jr, Ricardi U. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol 2014;9:1426-33. [PMID: 25170641 DOI: 10.1097/JTO.0000000000000317] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
69 deSouza NM, Liu Y, Chiti A, Oprea-lager D, Gebhart G, Van Beers BE, Herrmann K, Lecouvet FE. Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group. European Journal of Cancer 2018;91:153-63. [DOI: 10.1016/j.ejca.2017.12.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
70 Gössling GCL, Chedid MF, Pereira FS, da Silva RK, Andrade LB, Peruzzo N, Saueressig MG, Schwartsmann G, Parikh AR. Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience. Oncologist 2021;26:e1581-8. [PMID: 33896091 DOI: 10.1002/onco.13802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Gu Y, Zhang J, Zhou Z, Liu D, Zhu H, Wen J, Xu X, Chen T, Fan M. Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-based Study. Aging Dis 2020;11:82-92. [PMID: 32010483 DOI: 10.14336/AD.2019.0414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
72 Deutsch GB, Kirchoff DD, Faries MB. Metastasectomy for stage IV melanoma. Surg Oncol Clin N Am 2015;24:279-98. [PMID: 25769712 DOI: 10.1016/j.soc.2014.12.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
73 Wang HH, Zaorsky NG, Meng MB, Zeng XL, Deng L, Song YC, Zhuang HQ, Li FT, Zhao LJ, Yuan ZY, Wang P, Hao XS. Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes. Oncotarget 2016;7:18135-45. [PMID: 26919113 DOI: 10.18632/oncotarget.7636] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
74 Gmeiner WH, Ghosh S. Nanotechnology for cancer treatment. Nanotechnol Rev 2015;3:111-22. [PMID: 26082884 DOI: 10.1515/ntrev-2013-0013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
75 Navarria P, Ascolese AM, Tomatis S, Cozzi L, De Rose F, Mancosu P, Alongi F, Clerici E, Lobefalo F, Tozzi A. Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. Radiat Oncol. 2014;9:91. [PMID: 24694067 DOI: 10.1186/1748-717x-9-91] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
76 Aitken KL, Hawkins MA. Stereotactic body radiotherapy for liver metastases. Clin Oncol (R Coll Radiol). 2015;27:307-315. [PMID: 25682933 DOI: 10.1016/j.clon.2015.01.032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
77 Filippi AR, Badellino S, Ceccarelli M, Guarneri A, Franco P, Monagheddu C, Spadi R, Ragona R, Racca P, Ricardi U. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. Int J Radiat Oncol Biol Phys 2015;91:524-9. [PMID: 25542308 DOI: 10.1016/j.ijrobp.2014.10.046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
78 Mu L, Pan T, Lyu N, Sun L, Li S, Xie Q, Deng H, Wu P, Liu H, Zhao M. CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium. Lung Cancer 2018;122:25-31. [DOI: 10.1016/j.lungcan.2018.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
79 Guerrera F, Mossetti C, Ceccarelli M, Bruna MC, Bora G, Olivetti S, Lausi PO, Solidoro P, Ciccone G, Ruffini E, Oliaro A, Filosso PL. Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery. J Thorac Dis 2016;8:1764-71. [PMID: 27499967 DOI: 10.21037/jtd.2016.05.98] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
80 Tselikas L, Garzelli L, Mercier O, Auperin A, Lamrani L, Deschamps F, Yevich S, Roux C, Mussot S, Delpla A, Varin F, Hakime A, Teriitehau C, Le Péchoux C, Pradère P, Caramella C, Besse B, Fadel E, de Baere T. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease. Diagn Interv Imaging 2021;102:19-26. [PMID: 33020025 DOI: 10.1016/j.diii.2020.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ, van As NJ. Stereotactic body radiotherapy for oligometastases. Lancet Oncol. 2013;14:e28-e37. [PMID: 23276369 DOI: 10.1016/s1470-2045(12)70510-7] [Cited by in Crossref: 299] [Cited by in F6Publishing: 126] [Article Influence: 33.2] [Reference Citation Analysis]
82 路娜, 王雅棣. 局部治疗手段在结直肠癌肝转移治疗中的价值. 世界华人消化杂志 2017; 25(19): 1705-1713 [DOI: 10.11569/wcjd.v25.i19.1705] [Reference Citation Analysis]
83 Su X, Yang N, Wittrup KD, Irvine DJ. Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles. Biomacromolecules 2013;14:1093-102. [PMID: 23444913 DOI: 10.1021/bm3019906] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
84 Cacciola A, Parisi S, Tamburella C, Lillo S, Ferini G, Molino L, Iatì G, Pontoriero A, Bottari A, Mazziotti S, Cicero G, Minutoli F, Blandino A, Pergolizzi S. Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? Rep Pract Oncol Radiother 2020;25:299-306. [PMID: 32194349 DOI: 10.1016/j.rpor.2020.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
85 Widder J, Klinkenberg TJ, Ubbels JF, Wiegman EM, Groen HJ, Langendijk JA. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol. 2013;107:409-413. [PMID: 23773410 DOI: 10.1016/j.radonc.2013.05.024] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 8.3] [Reference Citation Analysis]
86 Kwon YS, Lee MG, Baek J, Nam KS, Lee JI, Kim S, Jang H. Evaluation of Radiotherapy-Induced Systemic Antitumor Effects in Mice Bearing 4T1 Mouse Breast Cancer Cells. Cancer Biother Radiopharm 2020. [PMID: 33259733 DOI: 10.1089/cbr.2020.3958] [Reference Citation Analysis]